1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Medicine Type
4.3.2 Market Segmentation by Platform Type
4.3.3 Market Segmentation by Product Type
4.3.4 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
7.2 Impact of Covid 19
7.2.1 Impact on Online Pharmacy Market
8 MARKET OPPORTUNITIES & TRENDS
8.1 Increased Health Awareness & Demand for Self-Medication
8.2 Increased Collaboration Among Stakeholders
8.3 Competitive Price, Heavy Promotion & Different Business Models
8.4 Rise in Direct-To-Patient Drug Sales
9 MARKET GROWTH ENABLERS
9.1 Rising Implementation Of E-Prescriptions in Hospitals & Healthcare Services
9.2 Improving Online Payments
9.3 Increase in Chronic Diseases & Aging Population
9.4 Increase in Teleconsultation & Diagnostic Support
10 MARKET RESTRAINTS
10.1 Low Penetration in Rural Areas of Developing Countries
10.2 Baby Boomer Population New to Internet Usage
10.3 Strict Regulatory Frameworks to Curb Illegal Online Pharmacy Practices
10.4 Stiff Competition & Low Profit Margins Due to Discounts
10.5 Sale of Unapproved Drugs & Opioids
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Market Share by Medicine Type
11.2.2 Market Share by Platform Type
11.2.3 Market Share by Product Type
11.2.4 Market by Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 MEDICINE TYPE
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 OTC Products
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 OTC Products: Market by Geography
12.4 Prescription Medicines
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Prescription Medicines: Market by Geography
13 PLATFORM TYPE
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Mobile
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Mobile: Market by Geography
13.4 Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Desktop: Market by Geography
14 PRODUCT TYPE
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Medications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Medications: Market by Geography
14.4 Health Wellness & Nutrition
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Health Wellness & Nutrition: Market by Geography
14.5 Personal Care & Essentials
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Personal Care & Essentials: Market by Geography
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Others: Market by Geography
15 GEOGRAPHY
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 NORTH AMERICA
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Medicine Type Segmentation
16.4 North America: Platform Type Segmentation
16.5 North America: Product Type Segmentation
16.7 North America: Key Countries
16.7.1 US: Market Size & Forecast
16.7.2 Canada: Market Size & Forecast
17 EUROPE
17.1 Market Overview
17.2 Market Snapshot & Growth Engine
18 EU5
18.1 Market Overview
18.2 Market Size & Forecast
18.3 EU5: Medicine Type Segment
18.4 EU5: Platform Type Segment
18.5 EU5: Product Type Segment
18.6 Key Countries
18.6.1 Germany: Market Size & Forecast
18.6.2 The UK: Market Size & Forecast
18.6.3 France: Market Size & Forecast
18.6.4 Italy: Market Size & Forecast
18.6.5 Spain: Market Size & Forecast
19 CENTRAL & EASTERN EUROPE
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Central & Eastern Europe: Medicine Type Segmentation
19.4 Central & Eastern Europe: Platform Type Segmentation
19.5 Central & Eastern Europe: Product Type Segmentation
19.6 Key Countries
19.6.1 Poland: Market Size & Forecast
19.6.2 Netherlands: Market Size & Forecast
19.6.3 Russia: Market Size & Forecast
19.6.4 Switzerland: Market Size & Forecast
19.6.5 Czech Republic: Market Size & Forecast
19.6.6 Hungary: Market Size & Forecast
20 NORDIC COUNTRIES
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Nordics: Medicine Type Segmentation
20.4 Nordic: Platform Type Segmentation
20.5 Nordic Countries: Product Type Segmentation
20.6 Key Countries
20.6.1 Denmark: Market Size & Forecast
20.6.2 Sweden: Market Size & Forecast
20.6.3 Norway: Market Size & Forecast
20.6.4 Finland: Market Size & Forecast
20.6.5 Iceland: Market Size & Forecast
21 APAC
21.1 Market Overview
21.2 Market Size & Forecast
21.3 APAC: Medicine Type Segmentation
21.4 APAC: Platform Type Segmentation
21.5 APAC: Product Type Segmentation
21.6 APAC: Key Countries
21.6.1 China: Market Size & Forecast
21.6.2 Japan: Market Size & Forecast
21.6.3 India: Market Size & Forecast
21.6.4 Australia: Market Size & Forecast
21.6.5 South Korea: Market Size & Forecast
22 LATIN AMERICA
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Latin America: Medicine Type Segmentation
22.4 Latin America: Platform Type Segmentation
22.5 Latin America: Product Type Segmentation
22.6 Latin America: Key Countries
22.6.1 Mexico: Market Size & Forecast
22.6.2 Argentina: Market Size & Forecast
22.6.3 Brazil: Market Size & Forecast
23 MIDDLE EAST & AFRICA
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Middle East & Africa: Medicine Type Segmentation
23.4 Middle East & Africa: Platform Type Segmentation
23.5 Middle East & Africa: Product Type Segmentation
23.6 Middle East & Africa: Key Countries
23.6.1 Saudi Arabia: Market Size & Forecast
23.6.2 UAE: Market Size & Forecast
23.6.3 South Africa: Market Size & Forecast
24 COMPETITIVE LANDSCAPE
24.1 Competition Overview
25 KEY COMPANY PROFILES
25.1 AMAZON PHARMACY
25.1.1 Business Overview
25.1.2 Key Strategies
25.1.3 Key Strengths
25.1.4 Key Opportunities
25.2 CIGNA (EXPRESS SCRIPTS)
25.2.1 Business Overview
25.2.2 Key Strategies
25.2.3 Key Strengths
25.2.4 Key Opportunities
25.3 CVS HEALTH
25.3.1 Business Overview
25.3.2 Key Strategies
25.3.3 Key Strengths
25.3.4 Key Opportunities
25.4 GIANT EAGLE
25.4.1 Business Overview
25.4.2 Key Strategies
25.4.3 Key Strengths
25.4.4 Key Opportunities
25.5 KROGER
25.5.1 Business Overview
25.5.2 Key Strategies
25.5.3 Key Strengths
25.5.4 Key Opportunities
25.6 SHOP APOTHEKE
25.6.1 Business Overview
25.6.2 Key Strategies
25.6.3 Key Strengths
25.6.4 Key Opportunities
25.7 WALGREENS BOOTS ALLIANCE
25.7.1 Business Overview
25.7.2 Key Strategies
25.7.3 Key Strengths
25.7.4 Key Opportunities
25.8 WALMART
25.8.1 Business Overview
25.8.2 Key Strategies
25.8.3 Key Strengths
25.8.4 Key Opportunities
25.9 ZUR ROSE GROUP
25.9.1 Business Overview
25.9.2 Key Strategies
25.9.3 Key Strengths
25.9.4 Key Opportunities
26 OTHER PROMINENT VENDORS
26.1 CHEMIST DIRECT
26.1.1 Business Overview
26.1.2 Key Strategy
26.1.3 Key Strengths
26.2 MEDLIFE
26.2.1 Business Overview
26.2.2 Key Strategies
26.2.3 Key Strengths
26.3 MONCOINSANTÉ
26.3.1 Business Overview
26.3.2 Key Strategies
26.3.3 Key Strengths
26.4 TATA 1MG
26.4.1 Business Overview
26.4.2 Key Strategy
26.4.3 Key Strengths
26.5 AMX HOLDINGS
26.5.1 Business Overview
26.5.2 Key Strategies
26.5.3 Key Strengths
26.6 APTEKA.RU
26.6.1 Business Overview
26.6.2 Key Strategies
26.6.3 Key Strengths
26.7 APOTEA
26.7.1 Business Overview
26.7.2 Key Strategies
26.7.3 Key Strength
26.8 AZETA
26.8.1 Business Overview
26.8.2 Key Strategies
26.8.3 Key Strength
26.9 BESTPHARMACY
26.9.1 Business Overview
26.9.2 Key Strategies
26.9.3 Key Strengths
26.10 BIOPLUS SPECIALTY PHARMACY
26.10.1 Business Overview
26.10.2 Key Strategy
26.10.3 Key Strength
26.11 CAREPOINT
26.11.1 Business Overview
26.11.2 Key Strategy
26.11.3 Key Strengths
26.12 CHEMIST 4 U
26.12.1 Business Overview
26.12.2 Key Strategies
26.12.3 Key Strength
26.13 COCOONCENTER
26.13.1 Business Overview
26.13.2 Key Strategies
26.13.3 Key Strength
26.14 DEONLINEDROGIST
26.14.1 Business Overview
26.14.2 Key Strategy
26.14.3 Key Strengths
26.15 FARMACIA INTERNACIONAL
26.15.1 Business Overview
26.15.2 Key Strategies
26.15.3 Key Strength
26.16 FOUNDATION CARE
26.16.1 Business Overview
26.16.2 Key Strategies
26.16.3 Key Strengths
26.17 GOGOMEDS
26.17.1 Business Overview
26.17.2 Key Strategy
26.17.3 Key Strength
26.18 HEALTHWAREHOUSE
26.18.1 Business Overview
26.19 HI-SCHOOL PHARMACY
26.19.1 Business Overview
26.20 HIMS &HERS HEALTH
26.20.1 Business Overview
26.21 HENRY FORD HEALTH SYSTEM
26.21.1 Business Overview
26.22 KINNEY DRUGS
26.22.1 Business Overview
26.23 KWIKMED
26.23.1 Business Overview
26.24 INDEX MEDICAL
26.24.1 Business Overview
26.24.2 Key Strategy
26.24.3 Key Strengths
26.25 INHOUSEPHARMACY
26.25.1 Business Overview
26.25.2 Key Strategy
26.25.3 Key Strength
26.26 JAPAN HEALTH CENTER
26.26.1 Business Overview
26.26.2 Key Strategy
26.26.3 Key Strength
26.27 LÉKÁRNA WPK
26.27.1 Business Overview
26.27.2 Key Strategy
26.27.3 Key Strength
26.28 LEKARNAR
26.28.1 Business Overview
26.28.2 Key Strategies
26.28.3 Key Strengths
26.29 LLOYDSPHARMACY
26.29.1 Business Overview
26.29.2 Key Strategy
26.29.3 Key Strengths
26.30 MEDEXPRESS
26.30.1 Business Overview
26.30.2 Key Strategy
26.30.3 Key Strength
26.31 MEDS
26.31.1 Business Overview
26.31.2 Key Strategies
26.31.3 Key Strength
26.32 MEDVANTX
26.32.1 Business Overview
26.32.2 Key Strategy
26.32.3 Key Strength
26.33 MYCARE
26.33.1 Business Overview
26.33.2 Key Strategy
26.33.3 Key Strengths
26.34 NETMEDS
26.34.1 Business Overview
26.34.2 Key Strategy
26.34.3 Key Strengths
26.35 NEWPHARMA
26.35.1 Business Overview
26.35.2 Key Strategies
26.35.3 Key Strengths
26.36 NORTHWESTPHARMACY.COM
26.36.1 Business Overview
26.36.2 Key Strategy
26.36.3 Key Strengths
26.37 NUNOKAME
26.37.1 Business Overview
26.37.2 Key Strategy
26.37.3 Key Strengths
26.38 OXFORD ONLINE PHARMACY
26.38.1 Business Overview
26.38.2 Key Strategy
26.38.3 Key Strengths
26.39 PARAFARMACIA-ONLINE
26.39.1 Business Overview
26.39.2 Key Strategy
26.39.3 Key Strengths
26.40 PHARM24
26.40.1 Business Overview
26.40.2 Key Strategies
26.40.3 Key Strengths
26.41 PHARMACY2U
26.41.1 Business Overview
26.41.2 Key Strategies
26.41.3 Key Strengths
26.42 PHARMACY4U
26.42.1 Business Overview
26.42.2 Key Strategy
26.42.3 Key Strength
26.43 PRVALEKARNA
26.43.1 Business Overview
26.43.2 Key Strategy
26.43.3 Key Strength
26.44 PROTEK GROUP
26.44.1 Business Overview
26.44.2 Key Strategies
26.44.3 Key Strength
26.45 RO PHARMACY
26.45.1 Business Overview
26.46 RX-24-ONLINE.COM
26.46.1 Business Overview
26.47 SANICARE
26.47.1 Business Overview
26.47.2 Key Strategies
26.47.3 Key Strengths
26.48 SBER EAPTEKA
26.48.1 Business Overview
26.48.2 Key Strategy
26.48.3 Key Strength
26.49 SIMPLE ONLINE PHARMACY
26.49.1 Business Overview
26.49.2 Key Strategy
26.49.3 Key Strength
26.50 THE CANADIAN PHARMACY
26.50.1 Business Overview
26.50.2 Key Strategy
26.50.3 Key Strength
26.51 UK MEDS
26.51.1 Business Overview
26.51.2 Key Strategies
26.51.3 Key Strengths
26.52 VAMIDA
26.52.1 Business Overview
26.52.2 Key Strategies
26.52.3 Key Strengths
26.53 WOORI PHARMACY
26.53.1 Business Overview
27 REPORT SUMMARY
27.1 Key Takeaways
27.2 Strategic Recommendations
28 QUANTITATIVE SUMMARY
28.1 Market by Geography
28.2 Market by Medicine Type
28.3 Market by Platform Type
28.4 Market by Product Type
28.5 North America: by Medicine Type
28.6 North America: by Platform Type
28.7 North America: by Product Type
28.8 Europe: by Medicine Type
28.9 Europe: by Platform Type
28.10 Europe: by Product Type
28.11 APAC: by Medicine Type
28.12 APAC: by Platform Type
28.13 APAC: by Product Type
28.14 Latin America: by Medicine Type
28.15 Latin America: by Platform Type
28.16 Latin America: by Product Type
28.17 Middle East & Africa: by Medicine Type
28.18 Middle East & Africa: by Platform Type
28.19 Middle East & Africa: by Product Type
29 APPENDIX
29.1 Abbreviations